A major advance in cancer research is emerging with the use of mini-antibodies to re-engage damaged p53. This essential cancer inhibitor protein is frequently inactivated in many types of malignancies, resulting https://mnobookmarks.com/story21852712/nanobodies-restore-tumor-suppressor-p53-new-potential-pathway-for-tumor-treatment